The Great Pharmaceutical Patent Debate
In recent news, the TAC (Treatment Action Campaign) has called on government to revise the Patents Act to reduce the patent protection available to pharmaceutical inventions, which the organisation believes is responsible for the high cost of medicines and a delay in the availability of generic medicines. The organisation refers to the Doha Declaration, which has been signed by South Africa as a member of the World Trade Organisation, to support its call. “Government has not yet been proactive in utilising these mechanisms” There is no denying that the impact of diseases such as...
Read More